Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
Clinical trial NCT04826523 · COMPLETED
Trial details
- NCT number
- NCT04826523
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-05
- Primary completion
- 2025-10-20
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.